GE Healthcare releases data supporting DaTscan for brain SPECT

05/1/2014 | (free registration)

GE Healthcare announced at the American Academy of Neurology annual meeting that its DaTscan tracer for use with SPECT brain imaging achieved an overall sensitivity of 91.9% and specificity of 83.6% when evaluated by onsite readers across four clinical trials and 88.7% sensitivity and 91.2% specificity under blind evaluation by independent experts. The tracer was used to detect striatal dopaminergic deficit, a condition linked to Parkinsonian syndromes.

View Full Article in: (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT